Edwards Lifesciences EW Japan — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's japan — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's japan — cost of sales?
- Edwards Lifesciences (EW) reported japan — cost of sales of $14.3M in Q1 2026.
- How has Edwards Lifesciences's japan — cost of sales changed year-over-year?
- Edwards Lifesciences's japan — cost of sales increased by 16.3% year-over-year, from $12.3M to $14.3M.
- What is the long-term trend for Edwards Lifesciences's japan — cost of sales?
- Over 3 years (2022 to 2025), Edwards Lifesciences's japan — cost of sales has grown at a 8.1% compound annual growth rate (CAGR), from $41.5M to $52.4M.
- What does japan — cost of sales mean?
- This metric captures the direct costs associated with producing and delivering medical devices sold within the Japanese market, including manufacturing, logistics, and distribution expenses. It is a critical component for evaluating the gross margin efficiency of the regional operations. Changes in this metric often reflect shifts in regional supply chain costs, manufacturing efficiencies, or product mix.